{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:15:24Z","timestamp":1792422924689,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"44","license":[{"start":{"date-parts":[[2012,12,3]],"date-time":"2012-12-03T00:00:00Z","timestamp":1354492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,12,3]],"date-time":"2012-12-03T00:00:00Z","timestamp":1354492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,10,31]]},"DOI":"10.1038\/onc.2012.550","type":"journal-article","created":{"date-parts":[[2012,12,3]],"date-time":"2012-12-03T17:59:47Z","timestamp":1354557587000},"page":"5210-5219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":310,"title":["Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche"],"prefix":"10.1038","volume":"32","author":[{"given":"F E","family":"Lock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P C","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S C","family":"Chafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ostlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-Y","family":"Winum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C T","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Dedhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,3]]},"reference":[{"key":"BFonc2012550_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S . Tumour stem cells and drug resistance. Nat Rev Cancer 2005; 5: 275\u2013284.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012550_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semradonc.2008.11.001","volume":"19","author":"CA O\u2019Brien","year":"2009","unstructured":"O\u2019Brien CA, Kreso A, Dick JE . Cancer stem cells in solid tumors: an overview. Semin Radiat Oncol 2009; 19: 71\u201377.","journal-title":"Semin Radiat Oncol"},{"key":"BFonc2012550_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL . Stem cells cancer and cancer stem cells. Nature 2001; 414: 105\u2013111.","journal-title":"Nature"},{"key":"BFonc2012550_CR4","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF . Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983\u20133988.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2012550_CR5","doi-asserted-by":"publisher","first-page":"R10","DOI":"10.1186\/bcr1855","volume":"10","author":"MH Wright","year":"2008","unstructured":"Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L . Brca1 breast tumors contain distinct CD44+\/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008; 10: R10.","journal-title":"Breast Cancer Res"},{"key":"BFonc2012550_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nrc1694","volume":"5","author":"T Brabletz","year":"2005","unstructured":"Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T . Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5: 744\u2013749.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012550_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10911-010-9173-1","volume":"15","author":"CJ Creighton","year":"2010","unstructured":"Creighton CJ, Chang JC, Rosen JM . Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 2010; 15: 253\u2013260.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"BFonc2012550_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704\u2013715.","journal-title":"Cell"},{"key":"BFonc2012550_CR9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1158\/0008-5472.CAN-07-2148","volume":"68","author":"AJ Trimboli","year":"2008","unstructured":"Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, Tanner SM et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 2008; 68: 937\u2013945.","journal-title":"Cancer Res"},{"key":"BFonc2012550_CR10","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","volume":"65","author":"D Ponti","year":"2005","unstructured":"Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem\/progenitor cell properties. Cancer Res 2005; 65: 5506\u20135511.","journal-title":"Cancer Res"},{"key":"BFonc2012550_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10911-012-9258-0","volume":"17","author":"LM Rota","year":"2012","unstructured":"Rota LM, Lazzarino DA, Ziegler AN, Leroith D, Wood TL . Determining mammosphere-forming potential: application of the limiting dilution analysis. J Mammary Gland Biol Neoplasia 2012; 17: 119\u2013123.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"BFonc2012550_CR12","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1634\/stemcells.2007-0724","volume":"26","author":"B Das","year":"2008","unstructured":"Das B, Tsuchida R, Malkin D, Koren G, Baruchel S, Yeger H . Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 2008; 26: 1818\u20131830.","journal-title":"Stem Cells"},{"key":"BFonc2012550_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.stem.2010.07.007","volume":"7","author":"A Mohyeldin","year":"2010","unstructured":"Mohyeldin A, Garzon-Muvdi T, Quinones-Hinojosa A . Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 2010; 7: 150\u2013161.","journal-title":"Cell Stem Cell"},{"key":"BFonc2012550_CR14","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1038\/onc.2011.122","volume":"30","author":"F Xing","year":"2011","unstructured":"Xing F, Okuda H, Watabe M, Kobayashi A, Pai SK, Liu W et al. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. Oncogene 2011; 30: 4075\u20134086.","journal-title":"Oncogene"},{"key":"BFonc2012550_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT . Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7: 168\u2013181.","journal-title":"Nat Rev Drug Discov"},{"key":"BFonc2012550_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0014-4827(03)00351-3","volume":"290","author":"E Svastova","year":"2003","unstructured":"Svastova E, Zilka N, Zat'ovicova M, Gibadulinova A, Ciampor F, Pastorek J et al. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin. Exp Cell Res 2003; 290: 332\u2013345.","journal-title":"Exp Cell Res"},{"key":"BFonc2012550_CR17","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1038\/onc.2010.455","volume":"29","author":"P Swietach","year":"2010","unstructured":"Swietach P, Hulikova A, Vaughan-Jones RD, Harris AL . New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation. Oncogene 2010; 29: 6509\u20136521.","journal-title":"Oncogene"},{"key":"BFonc2012550_CR18","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","volume":"71","author":"Y Lou","year":"2011","unstructured":"Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011; 71: 3364\u20133376.","journal-title":"Cancer Res"},{"key":"BFonc2012550_CR19","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.humpath.2007.01.008","volume":"38","author":"N Horree","year":"2007","unstructured":"Horree N, van Diest PJ, Sie-Go DM, Heintz AP . The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators. Hum Pathol 2007; 38: 1232\u20131238.","journal-title":"Hum Pathol"},{"key":"BFonc2012550_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/1471-2407-10-411","volume":"10","author":"P Bhat-Nakshatri","year":"2010","unstructured":"Bhat-Nakshatri P, Appaiah H, Ballas C, Pick-Franke P, Goulet R, Badve S et al. SLUG\/SNAI2 and tumor necrosis factor generate breast cells with CD44+\/CD24- phenotype. BMC Cancer 2010; 10: 411.","journal-title":"BMC Cancer"},{"key":"BFonc2012550_CR21","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/bcr2106","volume":"10","author":"MJ Grimshaw","year":"2008","unstructured":"Grimshaw MJ, Cooper L, Papazisis K, Coleman JA, Bohnenkamp HR, Chiapero-Stanke L et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res 2008; 10: R52.","journal-title":"Breast Cancer Res"},{"key":"BFonc2012550_CR22","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.ejca.2011.01.011","volume":"47","author":"JM Reuben","year":"2011","unstructured":"Reuben JM, Lee BN, Gao H, Cohen EN, Mego M, Giordano A et al. Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44CD24lo cancer stem cell phenotype. Eur J Cancer 2011; 47: 1527\u20131536.","journal-title":"Eur J Cancer"},{"key":"BFonc2012550_CR23","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.1158\/0008-5472.CAN-07-1486","volume":"67","author":"JC Liu","year":"2007","unstructured":"Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E . Identification of tumorsphere- and tumor-initiating cells in HER2\/Neu-induced mammary tumors. Cancer Res 2007; 67: 8671\u20138681.","journal-title":"Cancer Res"},{"key":"BFonc2012550_CR24","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821\u20135828.","journal-title":"Cancer Res"},{"key":"BFonc2012550_CR25","volume-title":"Limiting Dilution Analysis of Cells of the Immune System","author":"I Lefkovits","year":"1999","unstructured":"Lefkovits I, Waldmann H . Limiting Dilution Analysis of Cells of the Immune System 2nd edn. Oxford University Press, Oxford, New York, 1999, xvi 285: pp."},{"key":"BFonc2012550_CR26","doi-asserted-by":"publisher","first-page":"e21549","DOI":"10.1371\/journal.pone.0021549","volume":"6","author":"AD Balgi","year":"2011","unstructured":"Balgi AD, Diering GH, Donohue E, Lam KK, Fonseca BD, Zimmerman C et al. Regulation of mTORC1 signaling by pH. PLoS One 2011; 6: e21549.","journal-title":"PLoS One"},{"key":"BFonc2012550_CR27","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1242\/dev.058230","volume":"138","author":"RC Russell","year":"2011","unstructured":"Russell RC, Fang C, Guan KL . An emerging role for TOR signaling in mammalian tissue and stem cell physiology. Development 2011; 138: 3343\u20133356.","journal-title":"Development"},{"key":"BFonc2012550_CR28","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","volume":"71","author":"P Gulhati","year":"2011","unstructured":"Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 2011; 71: 3246\u20133256.","journal-title":"Cancer Res"},{"key":"BFonc2012550_CR29","doi-asserted-by":"publisher","first-page":"e16209","DOI":"10.1371\/journal.pone.0016209","volume":"6","author":"BY Shorning","year":"2011","unstructured":"Shorning BY, Griffiths D, Clarke AR . Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder. PLoS One 2011; 6: e16209.","journal-title":"PLoS One"},{"key":"BFonc2012550_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","volume":"110","author":"DH Kim","year":"2002","unstructured":"Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002; 110: 163\u2013175.","journal-title":"Cell"},{"key":"BFonc2012550_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/annonc\/mdi113","volume":"16","author":"S Vignot","year":"2005","unstructured":"Vignot S, Faivre S, Aguirre D, Raymond E . mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol 2005; 16: 525\u2013537.","journal-title":"Ann Oncol"},{"key":"BFonc2012550_CR32","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1128\/MCB.22.20.7004-7014.2002","volume":"22","author":"CC Hudson","year":"2002","unstructured":"Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, Kaper F et al. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 2002; 22: 7004\u20137014.","journal-title":"Mol Cell Biol"},{"key":"BFonc2012550_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1158\/1541-7786.MCR-08-0288","volume":"7","author":"KX Knaup","year":"2009","unstructured":"Knaup KX, Jozefowski K, Schmidt R, Bernhardt WM, Weidemann A, Juergensen JS et al. Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability. Mol Cancer Res 2009; 7: 88\u201398.","journal-title":"Mol Cancer Res"},{"key":"BFonc2012550_CR34","doi-asserted-by":"publisher","first-page":"18969","DOI":"10.1073\/pnas.0608636103","volume":"103","author":"KA Hartwell","year":"2006","unstructured":"Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC, Weinberg RA . The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci USA 2006; 103: 18969\u201318974.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2012550_CR35","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-09-2823","volume":"16","author":"A Pannuti","year":"2010","unstructured":"Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B et al. Targeting Notch to target cancer stem cells. Clin Cancer Res 2010; 16: 3141\u20133152.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012550_CR36","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1021\/jm101541x","volume":"54","author":"F Pacchiano","year":"2011","unstructured":"Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A et al. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem 2011; 54: 1896\u20131902.","journal-title":"J Med Chem"},{"key":"BFonc2012550_CR37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","volume":"15","author":"JM Ebos","year":"2009","unstructured":"Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS . Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009; 15: 232\u2013239.","journal-title":"Cancer Cell"},{"key":"BFonc2012550_CR38","doi-asserted-by":"publisher","first-page":"e10431","DOI":"10.1371\/journal.pone.0010431","volume":"5","author":"V Harma","year":"2010","unstructured":"Harma V, Virtanen J, Makela R, Happonen A, Mpindi JP, Knuuttila M et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 2010; 5: e10431.","journal-title":"PLoS One"},{"key":"BFonc2012550_CR39","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.1021\/jm200983e","volume":"54","author":"N Touisni","year":"2011","unstructured":"Touisni N, Maresca A, McDonald PC, Lou Y, Scozzafava A, Dedhar S et al. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. J Med Chem 2011; 54: 8271\u20138277.","journal-title":"J Med Chem"},{"key":"BFonc2012550_CR40","doi-asserted-by":"publisher","first-page":"e8377","DOI":"10.1371\/journal.pone.0008377","volume":"4","author":"WW Hwang-Verslues","year":"2009","unstructured":"Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST et al. Multiple lineages of human breast cancer stem\/progenitor cells identified by profiling with stem cell markers. PLoS One 2009; 4: e8377.","journal-title":"PLoS One"},{"key":"BFonc2012550_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555\u2013567.","journal-title":"Cell Stem Cell"},{"key":"BFonc2012550_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10549-011-1692-y","volume":"133","author":"AK Croker","year":"2011","unstructured":"Croker AK, Allan AL . Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDH(hi)CD44 (+) human breast cancer cells. Breast Cancer Res Treat 2011; 133: 75\u201387.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2012550_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/stem.563","volume":"29","author":"P Marcato","year":"2011","unstructured":"Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 2011; 29: 32\u201345.","journal-title":"Stem Cells"},{"key":"BFonc2012550_CR44","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138: 645\u2013659.","journal-title":"Cell"},{"key":"BFonc2012550_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000029240","volume":"65","author":"E Martinez-Moragon","year":"1998","unstructured":"Martinez-Moragon E, Aparicio J, Sanchis J, Menendez R, Cruz Rogado M, Sanchis F . Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respiration 1998; 65: 108\u2013113.","journal-title":"Respiration"},{"key":"BFonc2012550_CR46","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/cncy.20153","volume":"119","author":"ND Liao","year":"2011","unstructured":"Liao ND, Shieh JM, Lee WY . Diagnostic value of metabolic phenotypes in malignant pleural effusions: expression of GLUT1 and CAIX by immunocytochemistry. Cancer Cytopathol 2011; 119: 346\u2013353.","journal-title":"Cancer Cytopathol"},{"key":"BFonc2012550_CR47","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1158\/1078-0432.CCR-06-2971","volume":"13","author":"N Chaudary","year":"2007","unstructured":"Chaudary N, Hill RP . Hypoxia and metastasis. Clin Cancer Res 2007; 13: 1947\u20131949.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012550_CR48","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1172\/JCI32533","volume":"117","author":"P Sansone","year":"2007","unstructured":"Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 2007; 117: 3988\u20134002.","journal-title":"J Clin Invest"},{"key":"BFonc2012550_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1158\/1078-0432.CCR-09-1630","volume":"16","author":"E Charafe-Jauffret","year":"2010","unstructured":"Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 2010; 16: 45\u201355.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012550_CR50","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/1078-0432.1154.11.3","volume":"11","author":"BK Abraham","year":"2005","unstructured":"Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H . Prevalence of CD44+\/CD24-\/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 2005; 11: 1154\u20131159.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012550_CR51","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/emmm.201000093","volume":"2","author":"KM Smith","year":"2010","unstructured":"Smith KM, Datti A, Fujitani M, Grinshtein N, Zhang L, Morozova O et al. Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens. EMBO Mol Med 2010; 2: 371\u2013384.","journal-title":"EMBO Mol Med"},{"key":"BFonc2012550_CR52","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ki.2009.222","volume":"76","author":"VH Haase","year":"2009","unstructured":"Haase VH . Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease. Kidney Int 2009; 76: 492\u2013499.","journal-title":"Kidney Int"},{"key":"BFonc2012550_CR53","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.2353\/ajpath.2010.090233","volume":"177","author":"EA Barnes","year":"2010","unstructured":"Barnes EA, Kenerson HL, Jiang X, Yeung RS . Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition. Am J Pathol 2010; 177: 1765\u20131778.","journal-title":"Am J Pathol"},{"key":"BFonc2012550_CR54","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1158\/0008-5472.CAN-11-3760","volume":"72","author":"KM Joo","year":"2012","unstructured":"Joo KM, Jin J, Kim E, Ho Kim K, Kim Y, Gu Kang B et al. MET signaling regulates glioblastoma stem cells. Cancer Res 2012; 72: 3828\u20133838.","journal-title":"Cancer Res"},{"key":"BFonc2012550_CR55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/1476-4598-9-221","volume":"9","author":"XY Wang","year":"2010","unstructured":"Wang XY, Penalva LO, Yuan H, Linnoila RI, Lu J, Okano H et al. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Mol Cancer 2010; 9: 221.","journal-title":"Mol Cancer"},{"key":"BFonc2012550_CR56","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/jnci\/djq361","volume":"102","author":"AM Calcagno","year":"2010","unstructured":"Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD et al. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst 2010; 102: 1637\u20131652.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2012550_CR57","first-page":"5747","volume":"60","author":"A Oloumi","year":"2000","unstructured":"Oloumi A, MacPhail SH, Johnston PJ, Banath JP, Olive PL . Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. Cancer Res 2000; 60: 5747\u20135753.","journal-title":"Cancer Res"},{"key":"BFonc2012550_CR58","doi-asserted-by":"publisher","first-page":"21321","DOI":"10.1074\/jbc.M509731200","volume":"281","author":"FE Turner","year":"2006","unstructured":"Turner FE, Broad S, Khanim FL, Jeanes A, Talma S, Hughes S et al. Slug regulates integrin expression and cell proliferation in human epidermal keratinocytes. J Biol Chem 2006; 281: 21321\u201321331.","journal-title":"J Biol Chem"},{"key":"BFonc2012550_CR59","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402\u2013408.","journal-title":"Methods"},{"key":"BFonc2012550_CR60","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth1015","volume":"4","author":"GY Lee","year":"2007","unstructured":"Lee GY, Kenny PA, Lee EH, Bissell MJ . Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007; 4: 359\u2013365.","journal-title":"Nat Methods"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012550","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T10:34:09Z","timestamp":1687862049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,3]]},"references-count":60,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2013,10,31]]}},"alternative-id":["BFonc2012550"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.550","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,3]]},"assertion":[{"value":"19 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SD and CTS are founding members of MetaSignal Therapeutics Inc. PCM is a consultant for MetaSignal Therapeutics Inc. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}